SFX by Ex Libris Inc.

Title:	Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Guandalini, L yr:2012

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gouliaev, A H H. "Piracetam and other structurally related nootropics." Brain Research Reviews 19.2 (1994): 180-222.
description	2.	Kondratenko, Rodion V. "Novel nootropic dipeptide Noopept increases inhibitory synaptic transmission in CA1 pyramidal cells." Neuroscience Letters 476.2 (2010): 70-73.
description	3.	Blizzard, Timothy A. "Side chain SAR of bicyclic beta-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem." Bioorganic & medicinal chemistry letters 20.3 (2010): 918-921.
description	4.	Malykh,, Andrei G., Andrei G. "Piracetam and Piracetam-Like Drugs." Drugs 70.3 (2010): 287-312.
description	5.	Matsukuma I, I. "Synthesis and biological evaluation of 3-chloro-1-carbacephem compounds." Chemical & pharmaceutical bulletin 37.5 (1989): 1239-1244.
description	6.	Gualtieri, F. "Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs." Current pharmaceutical design 8.2 (2002): 125-38.
description	7.	Morozova Roche, Ludmilla A. "Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity." Journal of Molecular Biology 414.5 (2011): 699-712.
description	8.	Cakic, V. "Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology." Journal of Medical Ethics 35.10 (2009): 611-615.
description	9.	Gamoh, S. "Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats." Neuroscience 93.1 (1999): 237-41.
description	10.	Alekseev, K. "Pharmaceutical analysis and standardization of noopept tablets." Pharmaceutical chemistry journal 45.6 (2011): 377-380.
description	11.	Govoni, S. "Cognition enhancers between treating and doping the mind." Pharmacological research 57.3 (2008): 196-213.
description	12.	Skrebitskii, V. G. G. "Nootropic Dipeptide Noopept Enhances Inhibitory Synaptic Transmission in the Hippocampus." Bulletin of Experimental Biology and Medicine 158.3 (2015): 349-351.
description	13.	Hubschwerlen, C. "Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins." Journal of medicinal chemistry 41.21 (1998): 3972-3975.
description	14.	Sheehan, J. "General synthesis of the penicillins." Journal of the American Chemical Society 81 (1959): 5838-.
description	15.	Tan, Q. "4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: First boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity." Bioorganic and medicinal chemistry letters 20.8 (2010): 2622-2624.
description	16.	Macphail, K. "Impairment of contextual fear conditioning in rats by Group I mGluRs: reversal by the nootropic nefiracetam." Pharmacology, biochemistry and behavior 73.2 (2002): 391-9.
description	17.	Tarui, A. "Simple, chemoselective, and diastereoselective Reformatsky-type synthesis of ÃÂ±-bromo-ÃÂ±-fluoro-ÃÂ²-lactams." Tetrahedron letters 51.15 (2010): 2000-2003.
description	18.	Neelamkavil, S. "The discovery of azepane sulfonamides as potent 11?-HSD1 inhibitors." Bioorganic & medicinal chemistry letters 19.16 (2009): 4563-4565.
description	19.	L. Kovalenko, A. "Immunopharmacological properties of noopept." Bulletin of experimental biology and medicine 144.1 (2007): 49-52.
description	20.	Hoppe HL, H. "Otitis media: focus on antimicrobial resistance and new treatment options." American journal of health-system pharmacy 55.18 (1998): 1881-1897.